145 related articles for article (PubMed ID: 2095647)
1. [Immunoglobulin therapy of postoperative sepsis].
Wesoly C; Kipping N; Grundmann R
Z Exp Chir Transplant Kunstliche Organe; 1990; 23(4):213-6. PubMed ID: 2095647
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.
Buda S; Riefolo A; Biscione R; Goretti E; Cattabriga I; Grillone G; Bacchi-Reggiani L; Pacini D
J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247
[TBL] [Abstract][Full Text] [Related]
3. Use of IgM and IgA-enriched immunoglobulins in the treatment of severe sepsis and septic shock. Clinical experience.
Berlot G; Dimastromatteo G
Minerva Anestesiol; 2004 Oct; 70(10):739-43; 743-5. PubMed ID: 15516885
[TBL] [Abstract][Full Text] [Related]
4. Use of IgM enriched intravenous immunoglobulin (Pentaglobin) in bone marrow transplantation.
Poynton CH; Jackson S; Fegan C; Barnes RA; Whittaker JA
Bone Marrow Transplant; 1992 Jun; 9(6):451-7. PubMed ID: 1628130
[TBL] [Abstract][Full Text] [Related]
5. [The effect of pentaglobin therapy on prognosis in patients with severe sepsis].
Tuğrul S; Ozcan PE; Akinci O; Cağatay A; Cakar N; Esen F
Ulus Travma Derg; 2001 Oct; 7(4):219-23. PubMed ID: 11705075
[TBL] [Abstract][Full Text] [Related]
6. [Postoperative endotoxin determination and immunoglobulin therapy of infected patients in the intensive care unit].
Grundmann R; Hornung M
Zentralbl Chir; 1987; 112(14):885-95. PubMed ID: 3310451
[TBL] [Abstract][Full Text] [Related]
7. Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins.
Behre G; Schedel I; Nentwig B; Wörmann B; Essink M; Hiddemann W
Antimicrob Agents Chemother; 1992 Oct; 36(10):2139-46. PubMed ID: 1444293
[TBL] [Abstract][Full Text] [Related]
8. IgM-enriched immunoglobulin preparation for immunoprophylaxis in cardiac surgery.
Friedrich I; Silber RE; Baumann B; Fischer C; Holzheimer RG
Eur J Med Res; 2002 Dec; 7(12):544-9. PubMed ID: 12527500
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulins prevent the breakdown of the blood-brain barrier in experimentally induced sepsis.
Esen F; Senturk E; Ozcan PE; Ahishali B; Arican N; Orhan N; Ekizoglu O; Kucuk M; Kaya M
Crit Care Med; 2012 Apr; 40(4):1214-20. PubMed ID: 22202704
[TBL] [Abstract][Full Text] [Related]
10. [The therapy of gram-negative septicotoxic diseases with pentaglobin, an immunoglobulin with an elevated IgM content (a prospective, randomized clinical study)].
Schedel I; Dreichhausen U
Anesteziol Reanimatol; 1996; (3):4-9. PubMed ID: 8967617
[TBL] [Abstract][Full Text] [Related]
11. Comparison of early IgM-enriched immunoglobulin vs polyvalent IgG administration in score-identified postcardiac surgical patients at high risk for sepsis.
Pilz G; Appel R; Kreuzer E; Werdan K
Chest; 1997 Feb; 111(2):419-26. PubMed ID: 9041991
[TBL] [Abstract][Full Text] [Related]
12. Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis.
Norrby-Teglund A; Haque KN; Hammarström L
J Intern Med; 2006 Dec; 260(6):509-16. PubMed ID: 17116001
[TBL] [Abstract][Full Text] [Related]
13. Use of an immunoglobulin preparation enriched for IgM (Pentaglobin) for the treatment of acute graft-versus-host disease.
Klingemann HG; Barnett MJ; Reece DE; Shepherd JD; Phillips GL
Bone Marrow Transplant; 1990 Sep; 6(3):199-202. PubMed ID: 2252960
[TBL] [Abstract][Full Text] [Related]
14. To use or not to use? Polyclonal intravenous immunoglobulins for the treatment of sepsis and septic shock.
Neugebauer EA
Crit Care Med; 2007 Dec; 35(12):2855-6. PubMed ID: 18043203
[No Abstract] [Full Text] [Related]
15. [Use of octagam and pentaglobin in the treatment of severe sepsis in the neonatal period].
Barinov AV; Ol'mezov VV
Anesteziol Reanimatol; 1999; (3):59-60. PubMed ID: 10458040
[TBL] [Abstract][Full Text] [Related]
16. The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis [ISRCTN28863830].
Tugrul S; Ozcan PE; Akinci O; Seyhun Y; Cagatay A; Cakar N; Esen F
Crit Care; 2002 Aug; 6(4):357-62. PubMed ID: 12225613
[TBL] [Abstract][Full Text] [Related]
17. IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.
Hentrich M; Fehnle K; Ostermann H; Kienast J; Cornely O; Salat C; Ubelacker R; Buchheidt D; Behre G; Hiddemann W; Schiel X
Crit Care Med; 2006 May; 34(5):1319-25. PubMed ID: 16540956
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin therapy in patients with endotoxemia and postoperative sepsis--a prospective randomized study.
Grundmann R; Hornung M
Prog Clin Biol Res; 1988; 272():339-49. PubMed ID: 3293080
[No Abstract] [Full Text] [Related]
19. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.
Laupland KB; Kirkpatrick AW; Delaney A
Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465
[TBL] [Abstract][Full Text] [Related]
20. Efficiency of sepsis score, AT III- and endotoxin evaluation in predicting the prognosis of postoperative sepsis in the intensive care unit.
Kipping N; Grundmann R; Hornung M; Wesoly C
Prog Clin Biol Res; 1989; 308():637-42. PubMed ID: 2780719
[No Abstract] [Full Text] [Related]
[Next] [New Search]
